Androgen-insensitive prostate cancer Clinical Trials

Delta Trials tracks 3 clinical trials for Androgen-insensitive prostate cancer in its publicly accessible dataset. Among the listed trials, 0 open for participant enrollment and 1 trial have reached completion. This research is carried out at 8 clinical sites around the world. An additional 2 trials have active registrations outside the recruiting and completed categories. Since 2020, 2 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.